DE1219176B - Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe - Google Patents
Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter WirkstoffabgabeInfo
- Publication number
- DE1219176B DE1219176B DEH47032A DEH0047032A DE1219176B DE 1219176 B DE1219176 B DE 1219176B DE H47032 A DEH47032 A DE H47032A DE H0047032 A DEH0047032 A DE H0047032A DE 1219176 B DE1219176 B DE 1219176B
- Authority
- DE
- Germany
- Prior art keywords
- hour
- tablets
- polyethylene glycol
- distearate
- ingredients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14642261A | 1961-10-20 | 1961-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1219176B true DE1219176B (de) | 1966-06-16 |
Family
ID=22517286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DEH47032A Pending DE1219176B (de) | 1961-10-20 | 1962-09-28 | Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe |
Country Status (6)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3217071A1 (de) * | 1982-05-06 | 1983-11-10 | Rüdiger Dr. 6365 Rosbach Gröning | Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK132572C (da) * | 1971-11-17 | 1976-05-31 | Colgate Palmolive Co | Tandpasta |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
US5082655A (en) * | 1984-07-23 | 1992-01-21 | Zetachron, Inc. | Pharmaceutical composition for drugs subject to supercooling |
US4804548A (en) * | 1984-10-05 | 1989-02-14 | Warner-Lambert Company | Novel sweetener delivery systems |
US4828857A (en) * | 1984-10-05 | 1989-05-09 | Warner-Lambert Company | Novel sweetener delivery systems |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
-
0
- BE BE623704D patent/BE623704A/xx unknown
-
1962
- 1962-09-28 DE DEH47032A patent/DE1219176B/de active Pending
- 1962-10-10 GB GB38360/62A patent/GB967610A/en not_active Expired
- 1962-10-18 FR FR912603A patent/FR2172M/fr active Active
- 1962-10-19 ES ES0281704A patent/ES281704A1/es not_active Expired
-
1966
- 1966-12-31 MY MY6600083A patent/MY6600083A/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3217071A1 (de) * | 1982-05-06 | 1983-11-10 | Rüdiger Dr. 6365 Rosbach Gröning | Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe |
Also Published As
Publication number | Publication date |
---|---|
ES281704A1 (es) | 1963-04-16 |
GB967610A (en) | 1964-08-26 |
BE623704A (US07968547-20110628-C00004.png) | |
FR2172M (fr) | 1963-11-25 |
MY6600083A (en) | 1966-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT391806B (de) | Verfahren zur herstellung einer festen dispersion eines pharmakologischen wirkstoffes in einer polymeren matrix | |
DE2433285C2 (de) | Mikrokapseln enthaltende Arzneimittel in Form einer Mehrschichttablette und Verfahren zu ihrer Herstellung | |
DE1948019A1 (de) | Verfahren zur Herstellung von Arzneizubereitungen | |
DE3420283A1 (de) | Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung | |
DE1292783B (de) | Verfahren zum Herstellen einer Tablette mit Depotwirkung | |
DE69207799T2 (de) | Pharmazeutische Zubereitung mit verzögerter Wirkstoffreigabe und Verfahren zur Herstellung derselben | |
DE4332436A1 (de) | Cyclosporin enthaltende pharmazeutische Zusammensetzungen | |
DE3915150A1 (de) | Lang-wirkende diclofenac-natrium-praeparation | |
EP1028722B1 (de) | Pharmazeutisch wirksame zusammensetzung enthaltend artemisinin und/oder ein derivat von artemisinin | |
DE68902531T2 (de) | Dispergierbare zubereitung. | |
DE69712100T2 (de) | Valproinsäure enthaltende mikrosphären für orale verabreichung | |
EP0068450A2 (de) | Arzneiformen zur oralen Verabreichung | |
DE3126258A1 (de) | Nicht bittere arzneimittelzubereitung und verfahren zu ihrer herstellung | |
DE2546577B2 (de) | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden | |
DE69327745T2 (de) | Tablette zur langsamen Freisetzung von Natriumvalproat | |
DE2706660A1 (de) | Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung | |
DE1219176B (de) | Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe | |
DE3524003A1 (de) | Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung | |
DE60001266T2 (de) | Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung | |
EP1847258B1 (de) | Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate | |
DD202502A5 (de) | Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit | |
DE2425764A1 (de) | Tabletten | |
DE2439538B2 (de) | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe | |
DE3602577A1 (de) | 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen | |
DE1766546A1 (de) | Verfahren zur Herstellung von Arzneipillen oder Tabletten |